Medincell Sa Stock Buy Hold or Sell Recommendation
| MDCLF Stock | USD 14.00 7.02 100.57% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding MedinCell SA is 'Strong Buy'. Macroaxis provides MedinCell buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MDCLF positions.
Check out MedinCell Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as MedinCell and provide practical buy, sell, or hold advice based on investors' constraints. MedinCell SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
MedinCell |
Execute MedinCell Buy or Sell Advice
The MedinCell recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MedinCell SA. Macroaxis does not own or have any residual interests in MedinCell SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MedinCell's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Insignificant | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
MedinCell Trading Alerts and Improvement Suggestions
| MedinCell SA is way too risky over 90 days horizon | |
| MedinCell SA appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 4.09 M. Net Loss for the year was (24.81 M) with profit before overhead, payroll, taxes, and interest of 4.09 M. | |
| MedinCell SA has accumulated about 34.39 M in cash with (21.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
MedinCell Returns Distribution Density
The distribution of MedinCell's historical returns is an attempt to chart the uncertainty of MedinCell's future price movements. The chart of the probability distribution of MedinCell daily returns describes the distribution of returns around its average expected value. We use MedinCell SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MedinCell returns is essential to provide solid investment advice for MedinCell.
| Mean Return | 1.52 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 12.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MedinCell historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MedinCell Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MedinCell or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MedinCell's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MedinCell pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.51 | |
β | Beta against Dow Jones | 0.30 | |
σ | Overall volatility | 14.25 | |
Ir | Information ratio | 0.12 |
MedinCell Volatility Alert
MedinCell SA is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MedinCell's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MedinCell's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MedinCell Fundamentals Vs Peers
Comparing MedinCell's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MedinCell's direct or indirect competition across all of the common fundamentals between MedinCell and the related equities. This way, we can detect undervalued stocks with similar characteristics as MedinCell or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of MedinCell's fundamental indicators could also be used in its relative valuation, which is a method of valuing MedinCell by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MedinCell to competition |
| Fundamentals | MedinCell | Peer Average |
| Return On Asset | -0.4 | -0.14 |
| Operating Margin | (3.25) % | (5.51) % |
| Current Valuation | 190.33 M | 16.62 B |
| Shares Outstanding | 25.22 M | 571.82 M |
| Shares Owned By Insiders | 47.61 % | 10.09 % |
| Shares Owned By Institutions | 19.00 % | 39.21 % |
| Price To Book | 34.52 X | 9.51 X |
| Price To Sales | 31.58 X | 11.42 X |
| Revenue | 4.09 M | 9.43 B |
| Gross Profit | 4.09 M | 27.38 B |
| EBITDA | (21.45 M) | 3.9 B |
| Net Income | (24.81 M) | 570.98 M |
| Cash And Equivalents | 34.39 M | 2.7 B |
| Cash Per Share | 1.38 X | 5.01 X |
| Total Debt | 16.25 M | 5.32 B |
| Debt To Equity | 4.86 % | 48.70 % |
| Current Ratio | 2.84 X | 2.16 X |
| Book Value Per Share | (1.04) X | 1.93 K |
| Cash Flow From Operations | (21.36 M) | 971.22 M |
| Earnings Per Share | (0.88) X | 3.12 X |
| Number Of Employees | 151 | 18.84 K |
| Beta | 1.02 | -0.15 |
| Market Capitalization | 244.65 M | 19.03 B |
| Total Asset | 44.3 M | 29.47 B |
| Z Score | 9.0 | 8.72 |
| Net Asset | 44.3 M |
MedinCell Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MedinCell . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MedinCell Buy or Sell Advice
When is the right time to buy or sell MedinCell SA? Buying financial instruments such as MedinCell Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MedinCell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in MedinCell Pink Sheet
MedinCell financial ratios help investors to determine whether MedinCell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedinCell with respect to the benefits of owning MedinCell security.